Company Valuation: Abbott Laboratories

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 241,365 191,427 191,088 196,184 217,859 177,073 - -
Change - -20.69% -0.18% 2.67% 11.05% -18.72% - -
Enterprise Value (EV) 1 249,166 198,318 198,871 202,693 222,266 200,454 192,817 189,013
Change - -20.41% 0.28% 1.92% 9.66% -9.81% -3.81% -1.97%
P/E 35.7x 28.1x 33.8x 14.8x 33.7x 28.4x 22.1x 19.2x
PBR 6.93x 5.2x 4.94x 4.11x 4.18x 4.38x 3.44x 3.21x
PEG - -36.9x -2x 0x -0.7x -7.76x 0.8x 1.3x
Capitalization / Revenue 5.6x 4.39x 4.76x 4.68x 4.91x 3.52x 3.24x 3.02x
EV / Revenue 5.78x 4.54x 4.96x 4.83x 5.01x 3.98x 3.53x 3.22x
EV / EBITDA 19.4x 15.9x 19.5x 19.1x 18.9x 15.5x 13.4x 12x
EV / EBIT 22x 17.7x 22.3x 21.8x 21.6x 17.1x 14.8x 13.2x
EV / FCF 28.8x 25.4x 39.3x 31.9x 30.1x 25.3x 20.6x 18.5x
FCF Yield 3.47% 3.94% 2.54% 3.13% 3.33% 3.96% 4.85% 5.4%
Dividend per Share 2 1.82 1.92 2.08 2.24 2.4 2.587 2.721 2.858
Rate of return 1.29% 1.75% 1.89% 1.98% 1.92% 2.54% 2.68% 2.81%
EPS 2 3.94 3.91 3.26 7.64 3.72 3.584 4.603 5.284
Distribution rate 46.2% 49.1% 63.8% 29.3% 64.5% 72.2% 59.1% 54.1%
Net sales 1 43,075 43,653 40,109 41,950 44,328 50,312 54,699 58,667
EBITDA 1 12,815 12,485 10,188 10,635 11,735 12,939 14,441 15,804
EBIT 1 11,324 11,231 8,911 9,295 10,301 11,716 13,031 14,322
Net income 1 7,071 6,933 5,723 13,402 6,524 6,441 8,073 9,095
Net Debt 1 7,801 6,891 7,783 6,509 4,407 23,381 15,744 11,941
Reference price 2 140.74 109.79 110.07 113.11 125.29 101.66 101.66 101.66
Nbr of stocks (in thousands) 1,714,968 1,743,574 1,736,059 1,734,455 1,738,834 1,741,813 - -
Announcement Date 26/01/22 25/01/23 24/01/24 22/01/25 22/01/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
18.9x3.31x11.63x3.57% 107B
16.91x0.19x11.95x0.78% 59.14B
31.81x7.73x20.21x1.26% 51.89B
38.49x3.07x10.49x2.49% 42.57B
37.27x1.36x12x0.26% 32.88B
30.92x5.51x17.57x-.--% 29.21B
41.86x7.32x26.41x0.25% 24.89B
23.62x3.45x12.41x1.23% 20.9B
45.81x6.18x19.84x0.47% 20B
Average 31.73x 4.24x 15.83x 1.15% 43.12B
Weighted average by Cap. 28.05x 3.81x 14.59x 1.67%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. ABL Stock
  5. Valuation Abbott Laboratories